Abstract
Juvenile myelomonocytic leukemia (JMML) is a rare fatal hematopoietic disorder of early childhood. We are presenting a case of 9-month-old female child who was admitted with abdominal distension, irritability, and hepatosplenomegaly. Peripheral blood film examination showed leukoerythroblastosis with leukocytosis, absolute monocytosis, microcytic hypo chromic anemia, and thrombocytopenia. Bone marrow examination showed myeloid hyperplasia, Hb HPLC revealed normal HbF (1.3 %) and HbA2 (2.9 %). There was absolute gamma globulinemia and DCT positivity. Cytogenetic studies revealed a normal karyotype with absence of Philadelphia (Ph) chromosome, monosomy 7 or any other chromosomal abnormality. Diagnosis of JMML was rendered according to the diagnostic criteria laid down by WHO classification 2008 with presence of peripheral blood monocytosis >1 × 109/L, blasts <20 % of leucocytes in blood or nucleated cells in bone marrow, absence of Ph chromosome, presence of immature granulocytes in the blood and WBC count >10 × 109/L. The patient was then started on a regimen of chemotherapy to which she gave a promising response.
This is a preview of subscription content, log in via an institution to check access.
References
Niemeyer CM, Aricò M, Basso G et al (1997) Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood 89:3534–3543
Aricò M, Biondi A, Pui CH (1997) Juvenile myelomonocytic leukemia. Blood 90:479–488
Niemeyer CM, Fenu S, Hasle H, Mann G, Stary J, van Wering E (1998) Response. Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood 91:365–366
Vardiman JW, Brunning RD, Arber DA et al (2008) Introduction and overview of the classification of the myeloid neoplasms. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO Classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon
EWOG-MDS. Clinical trial protocol EWOG-MDS 2006 (2007) Prospective non-randomized multi-center study for epidemiology and characterization of myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML) in childhood
Cannat A, Seligmann M (1973) Immunoglobulin abnormalities in juvenile myelomonocytic leukemia. Br J Med 1:71
Lorenzana A, Lyons H, Sawaf H, Higgins M, Carrigan D, Emanuel PD (2002) Human herpesvirus 6 infection mimicking juvenile myelomonocytic leukemia in an infant. J Pediatr Hematol Oncol 24:136–141
Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A et al (2003) Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34:148–150
Alessandrino EP, Amadori S, Cazzola M, Locatelli F, Mecucci C, Morra E, Saglio G, Visani G, Tura S (2001) Myelodysplastic syndromes: recent advances. Haematologica 86:1124–1157. http://www.haematologica.it/content/86/11/1124.full.pdf+html
Kang HJ, Shin HY, Choi SH, Ahn HS (2004) Novel regimen for the treatment of juvenile myelomonocytic leukemia. Leuk Res 28:167–170
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sethi, N., Kushwaha, S., Dhingra, B. et al. Juvenile Myelomonocytic Leukemia. Indian J Hematol Blood Transfus 29, 164–166 (2013). https://doi.org/10.1007/s12288-012-0164-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-012-0164-9